Oct 2026· Pulmonary Circulation· Vol 16· 0 citations· 8 references
Medicine
TL;DR
This case achieved short‐term recovery of cardiac function and long‐term maintenance of pulmonary vascular stability and demonstrates that the transcatheter Potts shunt is a feasible and effective life‐prolonging treatment option for severe PAH, even in patients with a history of prior PDA closure.
Abstract
ABSTRACT We report the case of an 18‐year‐old female with progressive, end‐stage pulmonary arterial hypertension (PAH) despite receiving maximal triple combination therapy. The patient had a history of patent ductus arteriosus (PDA) closure at 15 months of age. Due to a pulmonary hypertensive crisis during anesthesia induction, a transcatheter Potts procedure was successfully performed under extracorporeal membrane oxygenation (ECMO) support, involving covered stent implantation just below the previous PDA occluder. At the 3‐month follow‐up, the patient demonstrated significant clinical improvement, shifting to WHO class II–III, with a dramatic decrease in NT‐proBNP (5406–512 pg/ml) and an increased 6‐min walk distance (< 300 to 390 m). This case achieved short‐term recovery of cardiac function and long‐term maintenance of pulmonary vascular stability and demonstrates that the transcatheter Potts shunt is a feasible and effective life‐prolonging treatment option for severe PAH, even in patients with a history of prior PDA closure.
It is suggested that short‐term perioperative sotatercept can serve as an effective acute rescue therapy to safeguard high‐risk surgical interventions in critical pediatric PAH.
Pediatric pulmonary arterial hypertension carries a poor prognosis. Reversed Potts shunt has been proposed as a bridge from medical therapy to lung transplantation, yet evidence supporting its ability to preserve right ventricular function and improve symptoms in this population remains limited.
Pediatric...
X. Lin, J. Yuan, M. Zeng et al.· European Heart Journal· 0 citations
ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dys...
Xiang Chen, Ze-Ying Zhang, Xiao-Ying Lan et al.· Pulmonary Circulation· 0 citations
This review covers the management of PDA in adults, highlighting the pathophysiology, morphological classification, clinical presentation, and current approaches to closure, with transcatheter closure currently the preferred approach.
Anthony J. Kaywood, Alishah Ahmadi, W. Frishman· Cardiology in Review· 0 citations
Percutaneous creation of an aorto-pulmonary (AP) shunt has been explored in preclinical models for over 15 years, yet its clinical application remains limited. Surgical AP shunts are widely used to augment pulmonary blood flow in cyanotic congenital heart disease, but repeated thoracic operations and general anesthesia...
Matija Bakoš, S. Georgiev, Kerstin Wustman et al.· Pediatric Cardiology· 0 citations
BACKGROUND
Bioprosthetic valve thrombosis is an uncommon but important cause of late bioprosthetic valve dysfunction after transcatheter aortic valve replacement (TAVR).
CASE SUMMARY
An 82-year-old man with a history of TAVR presented with worsening exertional dyspnea and orthostasis after recent left atrial appendag...
Peng-Ang Song, Jason Samii, Shawn McKissick et al.· JACC Case Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.